HAEMONETICS CORPORATION (HAE) Revenue 2017–2026
HAEMONETICS CORPORATION (HAE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.3BFY2026 · since FY2017: $886.1M → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.3B | -2.0% |
| FY2025 | $1.4B | +4.0% |
| FY2024 | $1.3B | +12.0% |
| FY2023 | $1.2B | +17.7% |
| FY2022 | $993.2M | +14.1% |
| FY2021 | $870.5M | -11.9% |
| FY2020 | $988.5M | +2.2% |
| FY2019 | $967.6M | +7.0% |
| FY2018 | $903.9M | +2.0% |
| FY2017 | $886.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice